Related Experiment Video
Updated: Aug 17, 2025

07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
3.7K
Recommendations for living donor kidney transplantation
Miguel Ángel Frutos1, Marta Crespo2, María de la Oliva Valentín3
1Nephrology Department, Hospital Regional Universitario de Málaga, Spain.
Nefrologia
|December 12, 2022
Summary
This guide updates evidence for living donor kidney transplantation (LDKT), offering clinicians tools for optimal donor and recipient evaluation. It emphasizes donor safety and informed consent, expanding criteria for accepting living kidney donors.
Area of Science:
- Nephrology
- Transplantation Medicine
- Surgical Sciences
Background:
- Living donor kidney transplantation (LDKT) is a critical treatment for chronic renal failure.
- The importance of living donors in kidney transplantation (KT) needs to be re-emphasized.
- Advancements in donation strategies and donor acceptance criteria are expanding LDKT accessibility.
Purpose of the Study:
- To provide clinicians with decision-making tools for evaluating living kidney donors and transplant recipients.
- To optimize outcomes for both donors and recipients in LDKT.
- To update evidence for the best chronic renal failure treatment when a living donor is available.
Main Methods:
- Evidence update for chronic renal failure treatment in LDKT.
- Incorporation of new donation forms: incompatible HLA/ABO donation and paired donation.
- Refined risk analysis for donor health and pre-donation evaluation protocols.
Main Results:
- Expanded criteria for accepting living kidney donors, including older donors and those with borderline clinical histories.
- Improved risk assessment and management strategies to protect donor health.
- Successful implementation of incompatible and paired donation strategies to increase transplantation rates.
Conclusions:
- This guide offers recommendations and suggestions to aid decision-making in LDKT, particularly in pre-donation evaluations.
- Ensuring informed consent through high-quality studies and information for donors and recipients is paramount.
- LDKT programs must prioritize donor safety and well-being throughout the evaluation and donation process.
Keywords:
ABO incompatibleAltruistic donorCrossmatchDesensitizationDonor lifestyleDonor profileDonor protectionDonor risksEnd stage renal diseaseEthicalGuidelinesHLA incompatibleHLA typingImmunosuppressionIncompatibilityLegalLiving donor nephrectomyLiving kidney donorLiving kidney transplantPaediatric transplantPaired renal transplantRejectionRenal transplantationRetransplantsSurgicalSurgical complicationsSurvivalRelated Concept Videos
Kidney Transplant I: Introduction
36
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
36
Kidney Transplant II: Surgical Procedure
52
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
52
Tissue Transplantation
467
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
467
Bone Marrow Sampling and Transplants
388
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
388
Kidney Transplant III: Nursing Management
59
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
59

